Literature DB >> 33717074

In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection.

Juliana de Melo Batista Dos Santos1, Camila Pereira Soares2, Fernanda Rodrigues Monteiro3,4, Ralyria Mello2, Jonatas Bussador do Amaral3, Andressa Simões Aguiar5,6, Mariana Pereira Soledade6, Carolina Sucupira6, Milena De Paulis7, Juliana Bannwart Andrade7, Flavia Jaqueline Almeida8, Marco Aurélio Palazzi Sáfadi8, Luciana Becker Mau9, Jamile Menezes Brasil9, Theresa Ramalho10, Flávio V Loures11, Rodolfo Paula Vieira1,12,13, Edison Luiz Durigon2,14, Danielle Bruna Leal de Oliveira2,14, André Luis Lacerda Bachi3,15.   

Abstract

Likely as in other viral respiratory diseases, SARS-CoV-2 elicit a local immune response, which includes production and releasing of both cytokines and secretory immunoglobulin (SIgA). Therefore, in this study, we investigated the levels of specific-SIgA for SARS-CoV-2 and cytokines in the airways mucosa 37 patients who were suspected of COVID-19. According to the RT-PCR results, the patients were separated into three groups: negative for COVID-19 and other viruses (NEGS, n = 5); negative for COVID-19 but positive for the presence of other viruses (OTHERS, n = 5); and the positive for COVID-19 (COVID-19, n = 27). Higher specific-SIgA for SARS-CoV-2, IFN-β, and IFN-γ were found in the COVID-19 group than in the other groups. Increased IL-12p70 levels were observed in OTHERS group as compared to COVID-19 group. When the COVID-19 group was sub stratified according to the illness severity, significant differences and correlations were found for the same parameters described above comparing severe COVID-19 to the mild COVID-19 group and other non-COVID-19 groups. For the first time, significant differences are shown in the airway's mucosa immune responses in different groups of patients with or without respiratory SARS-CoV-2 infection.
Copyright © 2021 Santos, Soares, Monteiro, Mello, Amaral, Aguiar, Soledade, Sucupira, De Paulis, Andrade, Almeida, Sáfadi, Mau, Brasil, Ramalho, Loures, Vieira, Durigon, de Oliveira and Bachi.

Entities:  

Keywords:  SARS-CoV-2; cytokine-immunological terms; mucosal immmunity; respiratory; secretory immunoglobulin A; viruses

Mesh:

Substances:

Year:  2021        PMID: 33717074      PMCID: PMC7946815          DOI: 10.3389/fimmu.2021.595343

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  59 in total

Review 1.  Bronchus- and nasal-associated lymphoid tissues.

Authors:  John Bienenstock; Mark R McDermott
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

2.  Role of interleukin-12 in primary influenza virus infection.

Authors:  J M Monteiro; C Harvey; G Trinchieri
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene.

Authors:  X Lu; D D Erdman
Journal:  Arch Virol       Date:  2006-02-26       Impact factor: 2.574

4.  Assessment of Serum Level of Interleukin-37 in Asthmatic Children at Benha University Hospital.

Authors:  Osama A Elfeky; Neveen T Abed; Sherin M Emam; Heba A Elsayed
Journal:  Egypt J Immunol       Date:  2018-06

5.  Neuro-immuno-endocrine modulation in marathon runners.

Authors:  Andre L L Bachi; Francisco J O Rios; Pedro Henrique Carr Vaisberg; Marcia Martins; Matheus Cavalcante de Sá; Angélica B Victorino; Roberta Foster; Ana Paula R Sierra; Maria Augusta P Dal'Molin Kiss; Mauro Vaisberg
Journal:  Neuroimmunomodulation       Date:  2014-08-27       Impact factor: 2.492

Review 6.  Suppression of inflammation and acquired immunity by IL-37.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 7.  Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Bhaskar Saha; Yashwant D Bansode; Sara Jafarzadeh
Journal:  Viral Immunol       Date:  2020-11-04       Impact factor: 2.257

Review 8.  Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response.

Authors:  E Kindler; V Thiel; F Weber
Journal:  Adv Virus Res       Date:  2016-09-09       Impact factor: 9.937

9.  COVID-19: a case for inhibiting IL-17?

Authors:  Omar Pacha; Mary Alice Sallman; Scott E Evans
Journal:  Nat Rev Immunol       Date:  2020-06       Impact factor: 53.106

10.  Secretory IgA in Mucosa of Pharynx and Larynx Plays an Important Role against Influenza A Virus Infection in Kidney Yang Deficiency Syndrome Model.

Authors:  Shaozhe Zhao; Lei Yuan; Yi Li; Longchan Liu; Zixin Luo; Qingtao Lv; Rong Rong; Yong Yang
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-29       Impact factor: 2.629

View more
  6 in total

1.  Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients.

Authors:  Juliana de Melo Batista Dos Santos; Jonatas Bussador do Amaral; Carolina Nunes França; Fernanda Rodrigues Monteiro; Anuska Marcelino Alvares-Saraiva; Sandra Kalil; Edison Luiz Durigon; Danielle Bruna Leal Oliveira; Silvia Sanches Rodrigues; Debora Heller; Eliane Aparecida Rosseto Welter; João Renato Rebello Pinho; Rodolfo P Vieira; André Luis Lacerda Bachi
Journal:  Front Immunol       Date:  2022-05-24       Impact factor: 8.786

2.  Salivary immunity of elite collegiate American football players infected with SARS-CoV-2 normalizes following isolation.

Authors:  Joshua Granger; Eunhan Cho; Kevin Lindsey; Nathan Lemoine; Derek Calvert; Jack Marucci; Shelly Mullenix; Hollis O'Neal; Brian A Irving; Neil Johannsen; Guillaume Spielmann
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

3.  Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.

Authors:  M Carmen Martin; Ana Jimenez; Nuria Ortega; Alba Parrado; Isabel Page; M Isabel Gonzalez; Lydia Blanco-Peris
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

Review 4.  Role of the humoral immune response during COVID-19: guilty or not guilty?

Authors:  Melyssa Yaugel-Novoa; Thomas Bourlet; Stéphane Paul
Journal:  Mucosal Immunol       Date:  2022-10-04       Impact factor: 8.701

5.  Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms.

Authors:  Diem-Lan Vu; Paola Martinez-Murillo; Laurent Kaiser; Arnaud M Didierlaurent; Fiona Pigny; Maria Vono; Benjamin Meyer; Christiane S Eberhardt; Sylvain Lemeille; Elodie Von Dach; Géraldine Blanchard-Rohner; Isabella Eckerle; Angela Huttner; Claire-Anne Siegrist
Journal:  J Clin Immunol       Date:  2021-09-28       Impact factor: 8.317

Review 6.  Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment.

Authors:  Richard J Head; Eugenie R Lumbers; Bevyn Jarrott; Felix Tretter; Gary Smith; Kirsty G Pringle; Saiful Islam; Jennifer H Martin
Journal:  Pharmacol Res Perspect       Date:  2022-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.